Reports - Carrier Screening Market
HealthcareCarrier Screening Market
Carrier Screening Market Valuation and Future Projections to 2035 by Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), by Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, Others), by End User (Hospitals & Clinics, Reference Laboratories, Physician Offices, Others), by Regions (North America, Europe, Asia Pacific, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Carrier Screening Market - Segment Analysis
1. Overview
2. Global Carrier Screening Market, 2021 - 2035 (USD Million)
3. Global Carrier Screening Market - by Type
3.1. By Expanded Carrier Screening
3.2. By Targeted Disease Carrier Screening
4. Global Carrier Screening Market - by Technology
4.1. By DNA Sequencing
4.2. By Polymerase Chain Reaction
4.3. By Microarrays
4.4. By Others
5. Global Carrier Screening Market - by End User
5.1. By Hospitals & Clinics
5.2. By Reference Laboratories
5.3. By Physician Offices
5.4. By Others
6. Global Carrier Screening Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Carrier Screening Market - Segment Analysis
1. Overview
2. North America Carrier Screening Market, 2021 - 2035 (USD Million)
3. North America Carrier Screening Market - by Type
3.1. By Expanded Carrier Screening
3.2. By Targeted Disease Carrier Screening
4. North America Carrier Screening Market - by Technology
4.1. By DNA Sequencing
4.2. By Polymerase Chain Reaction
4.3. By Microarrays
4.4. By Others
5. North America Carrier Screening Market - by End User
5.1. By Hospitals & Clinics
5.2. By Reference Laboratories
5.3. By Physician Offices
5.4. By Others
Chapter 5 Europe Carrier Screening Market - Segment Analysis
1. Overview
2. Europe Carrier Screening Market, 2021 - 2035 (USD Million)
3. Europe Carrier Screening Market - by Type
3.1. By Expanded Carrier Screening
3.2. By Targeted Disease Carrier Screening
4. Europe Carrier Screening Market - by Technology
4.1. By DNA Sequencing
4.2. By Polymerase Chain Reaction
4.3. By Microarrays
4.4. By Others
5. Europe Carrier Screening Market - by End User
5.1. By Hospitals & Clinics
5.2. By Reference Laboratories
5.3. By Physician Offices
5.4. By Others
Chapter 6 Asia Pacific Carrier Screening Market - Segment Analysis
1. Overview
2. Asia Pacific Carrier Screening Market, 2021 - 2035 (USD Million)
3. Asia Pacific Carrier Screening Market - by Type
3.1. By Expanded Carrier Screening
3.2. By Targeted Disease Carrier Screening
4. Asia Pacific Carrier Screening Market - by Technology
4.1. By DNA Sequencing
4.2. By Polymerase Chain Reaction
4.3. By Microarrays
4.4. By Others
5. Asia Pacific Carrier Screening Market - by End User
5.1. By Hospitals & Clinics
5.2. By Reference Laboratories
5.3. By Physician Offices
5.4. By Others
Chapter 7 Latin America Carrier Screening Market - Segment Analysis
1. Overview
2. Latin America Carrier Screening Market, 2021 - 2035 (USD Million)
3. Latin America Carrier Screening Market - by Type
3.1. By Expanded Carrier Screening
3.2. By Targeted Disease Carrier Screening
4. Latin America Carrier Screening Market - by Technology
4.1. By DNA Sequencing
4.2. By Polymerase Chain Reaction
4.3. By Microarrays
4.4. By Others
5. Latin America Carrier Screening Market - by End User
5.1. By Hospitals & Clinics
5.2. By Reference Laboratories
5.3. By Physician Offices
5.4. By Others
Chapter 8 Middle East & Africa Carrier Screening Market - Segment Analysis
1. Overview
2. Middle East & Africa Carrier Screening Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Carrier Screening Market - by Type
3.1. By Expanded Carrier Screening
3.2. By Targeted Disease Carrier Screening
4. Middle East & Africa Carrier Screening Market - by Technology
4.1. By DNA Sequencing
4.2. By Polymerase Chain Reaction
4.3. By Microarrays
4.4. By Others
5. Middle East & Africa Carrier Screening Market - by End User
5.1. By Hospitals & Clinics
5.2. By Reference Laboratories
5.3. By Physician Offices
5.4. By Others
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Invitae (US)
2. Eurofins Scientific (US)
3. Fulgent Genetics (US)
4. OPKO Health (US)
5. Quest Diagnostics (US)
6. Myriad Genetics (US)
7. Sema4 (US)
8. Thermo Fisher Scientific (US) and Illumina (US)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By